Search - tctmd.com

Displaying 1 - 20 of 231

Sort: Relevancy | Date

Presentation TVT 2022

St. Paul’s Hospital, Vancouver, Canada - TAV in TAV

Presenter: John Webb

June 09, 2022

Presentation TCT 2019

The Vancouver 3M Pathway: Data Review, Practical Implementation, and the Importance of Patient-Centric Decision-Making

Presenter: Sandra Lauck

September 26, 2019

Presentation SCAD 2018

The Vancouver SCAD Cardiac Rehab Program

Presenter: Taira Birnie

September 07, 2018

Presentation The Structural Heart Disease Summit 2018

The Vancouver Minimalist Clinical Care Pathway: Updates from the 3M Trial and Evolution to BENCHMARK

Presenter: Vinod H. Thourani, John G. Webb, David A. Wood

June 22, 2018

Presentation TCT 2017

Featured Lecture: The Vancouver Multidisciplinary, Multimodality, but Minimalist Clinical Pathway Facilitates Safe Next Day Discharge Home at Low, Medium, and High Volume Transcatheter Aortic Valve Replacement Centres: the 3M TAVR Study

Presenter: Robert O. Bonow, Michael J. Mack, David A. Wood

October 30, 2017

Presentation TCT 2016

Late (>5 years) Clinical and Echo Outcomes After TAVR II: The Vancouver Experience

Presenter: Raj Makkar, Lars Sondergaard, John G. Webb

October 31, 2016

Presentation TVT 2016

Ten-year Follow-Up of TAVI From Vancouver

Presenter: John G. Webb

June 17, 2016

Presentation TCT 2015

Early Discharge After TAVR: The Vancouver Clinical Pathway, Including the North America 3M Study

Presenter: Ganesh Manoharan, Mathew Williams, Danny Dvir

October 15, 2015

Presentation TVT 2015

The Vancouver Postprocedural Clinical Pathway for Safe Next-Day Discharge Home

Presenter: Sandra Lauck

June 04, 2015

Presentation TVT 2014

Postdilation After TAVR can be Guided Largely Using Hemodynamic Assessments

Presenter: Jeffrey J. Popma

June 07, 2014

Presentation TVT 2014

A Critical Analysis of Present Data on Cerebral Protection after TAVR

Presenter: Axel Linke

June 07, 2014

Presentation TVT 2014

Indications, Technique, and Results of Postdilation After CoreValve

Presenter: Nicolas M. van Mieghem

June 07, 2014

Presentation TVT 2014

Why Cerebral Protection after TAVR Will Become the Standard of Care

Presenter: Eberhard Grube

June 07, 2014

Presentation TVT 2014

Postdilation After TAVR: (1) When is it Indicated? (2) Is it Safe? (3) What are the Outcomes?

Presenter: Rebecca T. Hahn

June 07, 2014

Presentation TVT 2014

Why Cerebral Protection after TAVR Will be Used Sparingly (if at all) in the Future

Presenter: Ganesh Manoharan

June 07, 2014

Presentation TVT 2014

Perspectives on Predilation from an Experienced SAPIEN User

Presenter: Raj Makkar

June 07, 2014

Presentation TVT 2014

A Rationale Approach to Adjunct Pharmacotherapy After TAVR (With Stroke in Mind)

Presenter: Susheel Kodali

June 07, 2014

Presentation TVT 2014

Reasons and Results of NO Predilation Before TAVR: How to Improve Outcomes and SIMPLIFY Your Life

Presenter: Mathew Williams

June 07, 2014

Presentation TVT 2014

General Anesthesia is a Liability and TEE is Mostly Unnecessary!

Presenter: Ganesh Manoharan

June 07, 2014

Presentation TVT 2014

Has Stroke Frequency Declined After TAVR?

Presenter: Nicolas M. van Mieghem

June 07, 2014

Advertisement

St. Paul’s Hospital, Vancouver, Canada - TAV in TAV

The Vancouver 3M Pathway: Data Review, Practical Implementation, and the Importance of Patient-Centric Decision-Making

The Vancouver SCAD Cardiac Rehab Program

The Vancouver Minimalist Clinical Care Pathway: Updates from the 3M Trial and Evolution to BENCHMARK

Featured Lecture: The Vancouver Multidisciplinary, Multimodality, but Minimalist Clinical Pathway Facilitates Safe Next Day Discharge Home at Low, Medium, and High Volume Transcatheter Aortic Valve Replacement Centres: the 3M TAVR Study

Late (>5 years) Clinical and Echo Outcomes After TAVR II: The Vancouver Experience

Ten-year Follow-Up of TAVI From Vancouver

Early Discharge After TAVR: The Vancouver Clinical Pathway, Including the North America 3M Study

The Vancouver Postprocedural Clinical Pathway for Safe Next-Day Discharge Home

Postdilation After TAVR can be Guided Largely Using Hemodynamic Assessments

A Critical Analysis of Present Data on Cerebral Protection after TAVR

Indications, Technique, and Results of Postdilation After CoreValve

Why Cerebral Protection after TAVR Will Become the Standard of Care

Postdilation After TAVR: (1) When is it Indicated? (2) Is it Safe? (3) What are the Outcomes?

Why Cerebral Protection after TAVR Will be Used Sparingly (if at all) in the Future

Perspectives on Predilation from an Experienced SAPIEN User

A Rationale Approach to Adjunct Pharmacotherapy After TAVR (With Stroke in Mind)

Reasons and Results of NO Predilation Before TAVR: How to Improve Outcomes and SIMPLIFY Your Life

General Anesthesia is a Liability and TEE is Mostly Unnecessary!

Has Stroke Frequency Declined After TAVR?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content